Targeted therapy for advanced anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer.

ABSTRACT:

SUBMITTER: Cameron LB 

PROVIDER: S-EPMC8740884 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature